| Study of the association of 17 lipid-related gene polymorphisms with coronary heart disease | Nan WU,Guili LİU,Yi HUANG,Qi LİAO,Liyuan HAN,Huandan YE,Shiwei DUAN,Xiaomin CHEN | 360–367 |
| Admission glycemic variability correlates with in-hospital outcomes in diabetic patients with non-ST segment elevation acute coronary syndrome undergoing percutaneous coronary intervention | Gong SU,Tao ZHANG,Hongxia YANG,Wenlong DAİ,Lei TIAN,Hong TAO,Tao WANG,Shuhua Mİ | 368–373 |
| Association of serum levels of lipoprotein A-I and lipoprotein A-I/A-II with high on-treatment platelet reactivity in patients with ST-segment elevation myocardial infarction | Aleksander SİNİARSKİ,Rafał GRZYBCZAK,Paweł ROSTOFF,Jarosław ZALEWSKİ,Urszula CZUBEK,Jadwiga NESSLER,Grzegorz GAJOS | 374–381 |
| Major adverse cardiac events and drug-coated balloon size in coronary interventions | David NAGUİB,Betül KNOOP,Lisa DANNENBERG,Eva LİEBSCH,Martin PÖHL,Carolin HELTEN,Athena ASSADİ-SCHMİDT,Malte KELM,Tobias ZEUS,Amin POLZİN | 382–387 |
| Speckle-tracking strain assessment of left ventricular dysfunction in synthetic cannabinoid and heroin users | Aykut DEMİRKİRAN,Neslihan ALBAYRAK,YAKUP ALBAYRAK,Cafer Sadık ZORKUN | 388–393 |
| Postoperative atrial fibrillation prediction following isolated surgical aortic valve replacement | Alina Cristina ILİESCU,Delia Lidia SALARU,Ionut ACHİTEİ,Mihaela GRECU,Mariana FLORİA,Grigore TINICA | 394–400 |
| Current state of risk stratification for sudden cardiac death in adults with congenital heart disease | Jim T. VEHMEİJER,Barbara J. M. MULDER,Joris R. de GROOT | 401–403 |
| Role of cardiac T1 mapping and extracellular volume in the assessment of myocardial infarction | Pankaj GARG,Laura C. SAUNDERS,Andrew J. SWİFT,Jim M. WİLD,Sven PLEİN | 404–411 |
| Dobutamine-induced takotsubo cardiomyopathy: A systematic review of the literature and case report | Shokoufeh HAJSADEGHİ,Mohammad Hossein RAHBAR,Aida IRANPOUR,Ali SALEHİ,Omolbanin ASADİ,Scott R. JAFARİAN | 412–416 |
| A case with a giant interatrial septal lipomatous hypertrophy, and thickened epicardial and visceral fat: Different faces of a common metabolic problem? |